RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
Adjuvant #Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/xzWWDJgezk @NEJM #ECM
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
This figure also represents the mortality benefit of the inpatient cardiac diet v. regular. https://t.co/1riYW8i7lt
Now we need to figure out whether the benefit for premenopausal patients was truly from chemo or was from the ovarian suppression chemo provided. Also need more info on score 25-31. https://t.co/5V7S1549pE
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial:…
Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s Editorial: TAILORing Adjuvant Systemic Therapy for Breast Cancer https://t.co/b33uUXT4Sl https://t.co/M6Ut7A1M7t
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/EHqnJmrgeB
#Precision medicine in #breastcancer using #Genetics risk score with tailored therapy and prediction of recurrence. https://t.co/K61k34XORm
TAILORxの結果がNEJMに載りました。 Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/AEXQNFRBva
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
21-Gene Expression Assay in #Breast #Cancer! Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #Breast #Cancer https://t.co/GBxKpSBBLc https://t.co/NYtL0S3u82
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
TAILORx shows that some women with #breastcancer can skip chemo altogether! Read the latest form Dr. @JSparano, et al! https://t.co/nqVQHLBrdm
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
Long awaited results indicating most women with er positive node negative cancers don’t need chemotherapy. https://t.co/PUVJ4i1Dyx
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
RT @NEJM: A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it i…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it is low, but the benefit of chemotherapy for those with a midrange score is unknown. Learn more about this study: https://t.co/rQ
RT Transplant_Doc "Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/Qf8t4XPulG"
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/S1g5yTUD6C
New milestone in clinical impact of #biomarker research - #Oncotype DX 21-gene #expression assay helps decisions about adjuvant chemotherapy in breast cancer | NEJM https://t.co/HokjEARhos
Where can I find information about each cancer sample, cancer cell enrichment techniques (if used) and a general overview of the quality of the biologic material that underwent the analysis ? Many thanks. https://t.co/uosFOpvBEo
Looking into a grey area: adjuvant chemotherapy not necessary for a large proportion of women with early-stage breast cancer and midrange genetic score. https://t.co/KIQWxZT650
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @writeo: Great news for #women with breast #cancer. https://t.co/DLO75VINXq
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
Great news for #women with breast #cancer. https://t.co/zkzce25ETR
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
RT @NEJM: Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrang…
Study finds that endocrine therapy alone is non-inferior to chemoendocrine therapy for women with early #breastcancer and midrange recurrence scores. Full trial results: https://t.co/rQ4b15lb0s #TAILORx https://t.co/MSGjvMbfeu
Open access link for the TAILORx trial | Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/kVtJ1kIROx
RT @Sjaakjacob1234: Tot +-3000 vroege NLborstkanker - zou geen chemotherapie nodig hebben omgerekent analoog USAcijfers naar nieuwste stud…
Tot +-3000 vroege NLborstkanker - zou geen chemotherapie nodig hebben omgerekent analoog USAcijfers naar nieuwste studie 10.06.2018 / Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM -https://t.co/p1G3NiP4Ir
Unnecessary adjuvant chemotherapy in breast #cancer, but why? https://t.co/y3i78QKVSD #FOAMed #oncology #BCSM https://t.co/sOkBKWpiPI
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/8rkhqNBBpj
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
Results from the #TAILORx study: a prospective look at women at mid-risk for #breastcancer recurrence shows chemo+hormone therapy was not superior to hormone therapy alone. https://t.co/WWMaJJ8vJe https://t.co/FlxONEL0Oe
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/YHDFv057ej
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx ht…
Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer https://t.co/rQ4b15lb0s #TAILORx https://t.co/MNsQzPewCC
RT @OncotypeIQ: View the full #TAILORx #breastcancer trial results published in @NEJM! https://t.co/W8x5ypYfjS
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer https://t.co/rQ4b15lb0s https://t.c…
RT @DrTashaG: Results of TAILORx study will be practice changing! Patients with ER positive, Her2 negative, node negative and a mid-range 2…
RT @OncotypeIQ: View the full #TAILORx #breastcancer trial results published in @NEJM! https://t.co/W8x5ypYfjS
RT @OncotypeIQ: View the full #TAILORx #breastcancer trial results published in @NEJM! https://t.co/W8x5ypYfjS